Xontogeny, LLC

Insider CIK 1844296 · CATB Director, 10% owner · LABP Director, 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
LABP Landos Biopharma, Inc.	A Award deriv	2021-08-27	2021-08-31	10,709	—	$0	10,709	SEC↗
LABP Landos Biopharma, Inc.	P Buy	2021-02-09	2021-02-09	34,951	$14.60	$510.3K	7,299,751	SEC↗
LABP Landos Biopharma, Inc.	P Buy	2021-02-09	2021-02-09	64,730	$13.80	$893.3K	7,264,800	SEC↗
LABP Landos Biopharma, Inc.	C Conversion deriv	2021-02-08	2021-02-08	2,941,769	—	$0	0	SEC↗
LABP Landos Biopharma, Inc.	C Conversion deriv	2021-02-08	2021-02-08	2,857,795	—	$0	0	SEC↗
LABP Landos Biopharma, Inc.	C Conversion deriv	2021-02-08	2021-02-08	2,857,795	—	$0	0	SEC↗
LABP Landos Biopharma, Inc.	C Conversion deriv	2021-02-08	2021-02-08	2,941,769	—	$0	0	SEC↗
LABP Landos Biopharma, Inc.	C Conversion deriv	2021-02-08	2021-02-08	1,770,600	—	$0	0	SEC↗
LABP Landos Biopharma, Inc.	C Conversion	2021-02-08	2021-02-08	2,857,795	—	$0	5,799,564	SEC↗
LABP Landos Biopharma, Inc.	C Conversion	2021-02-08	2021-02-08	2,941,769	—	$0	2,941,769	SEC↗
LABP Landos Biopharma, Inc.	C Conversion	2021-02-08	2021-02-08	1,770,600	—	$0	1,770,600	SEC↗
LABP Landos Biopharma, Inc.	P Buy	2021-02-08	2021-02-08	1,250,000	$16.00	$20.00M	7,049,564	SEC↗
LABP Landos Biopharma, Inc.	C Conversion	2021-02-08	2021-02-08	2,857,795	—	$0	5,799,564	SEC↗
LABP Landos Biopharma, Inc.	C Conversion	2021-02-08	2021-02-08	2,941,769	—	$0	2,941,769	SEC↗
LABP Landos Biopharma, Inc.	P Buy	2021-02-08	2021-02-09	1,771	$13.10	$23.2K	7,200,070	SEC↗
LABP Landos Biopharma, Inc.	P Buy	2021-02-08	2021-02-09	86,671	$12.53	$1.09M	7,198,299	SEC↗
LABP Landos Biopharma, Inc.	P Buy	2021-02-08	2021-02-09	34,611	$11.38	$393.9K	7,111,628	SEC↗
LABP Landos Biopharma, Inc.	P Buy	2021-02-05	2021-02-09	27,453	$11.14	$305.8K	7,077,017	SEC↗
CATB CATABASIS PHARMACEUTICALS	A Award deriv	2021-02-01	2021-02-03	4,851	$3009.53	$14.60M	4,851	SEC↗
CATB CATABASIS PHARMACEUTICALS	A Award deriv	2021-02-01	2021-02-03	1,617	$3009.53	$4.87M	30,920	SEC↗